Breaking News Instant updates and real-time market news.

GLP

Global Partners

$12.73 /

+0.44 (+3.58%)

08:13
08/06/20
08/06
08:13
08/06/20
08:13

Global Partners reports Q2 EPS $2.17 vs. 36c last year

Reports Q2 revenue $1.47B, two estimates $2.55B. "We delivered strong results in the second quarter, reflecting the extreme contango market structure," said Eric Slifka, the Partnership's President and CEO. "Our terminal network enabled us to benefit from a dramatic shift in the forward product pricing curve in Q2, leading to a $73.5 million increase in Wholesale product margin from the same period last year. The Q2 increase sharply contrasts with the nearly $30 million decline in Wholesale segment product margin in the first quarter this year, which reflected less favorable market conditions due in part to the steepening forward curve. In our Gasoline Distribution and Station Operations (GDSO) segment, our second-quarter 2020 results benefited from higher fuel margins that more than offset a year-over-year decline in volume related to COVID-19. Business activity remains below pre-pandemic levels. In comparison with July 2019, in July 2020 retail gas volume was down mid-teens on a percentage basis and convenience store sales were down less than 10%. That said, the extent to which the COVID-19 pandemic may affect our operating results remains uncertain."

  • 06

    Aug

GLP Global Partners
$12.73 /

+0.44 (+3.58%)

03/24/20 Barclays
Global Partners upgraded to Equal Weight from Underweight at Barclays
01/29/20 JPMorgan
JPMorgan downgrades four MLPs to Underweight from Neutral
01/29/20 JPMorgan
Global Partners downgraded to Underweight from Neutral at JPMorgan
01/07/20 Wells Fargo
Global Partners downgraded to Underweight at Wells Fargo

TODAY'S FREE FLY STORIES

Downgrade
Wienerberger downgraded to Neutral from Outperform at Exane BNP Paribas » 05:09
09/21/20
09/21
05:09
09/21/20
05:09
WBRBY

Wienerberger

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WBRBY Wienerberger
$0.00 /

+ (+0.00%)

08/20/20 UBS
Wienerberger price target raised to EUR 23 from EUR 22 at UBS
08/18/20 Berenberg
Wienerberger price target raised to EUR 26 from EUR 25 at Berenberg
08/13/20 Deutsche Bank
Wienerberger price target raised to EUR 25 from EUR 23 at Deutsche Bank
07/31/20 Berenberg
Wienerberger initiated with a Buy at Berenberg
Hot Stocks
Wheaton Precious Metals to seek secondary listing on London Stock Exchange » 05:09
09/21/20
09/21
05:09
09/21/20
05:09
WPM

Wheaton Precious Metals

$51.18 /

-1.42 (-2.70%)

Wheaton Precious Metals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WPM Wheaton Precious Metals
$51.18 /

-1.42 (-2.70%)

WPM Wheaton Precious Metals
$51.18 /

-1.42 (-2.70%)

09/11/20 National Bank
Wheaton Precious Metals price target raised to C$90 from C$78 at National Bank
08/19/20 BMO Capital
Wheaton Precious Metals cut to Market Perform from Outperform at BMO Capital
07/22/20 Credit Suisse
Wheaton Precious Metals price target raised to C$65 from C$57 at Credit Suisse
07/20/20 Barclays
Wheaton Precious downgraded to Underweight on valuation at Barclays
WPM Wheaton Precious Metals
$51.18 /

-1.42 (-2.70%)

WPM Wheaton Precious Metals
$51.18 /

-1.42 (-2.70%)

Downgrade
United Internet downgraded to Underperform from Neutral at Exane BNP Paribas » 05:09
09/21/20
09/21
05:09
09/21/20
05:09
UDIRF

United Internet

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UDIRF United Internet
$0.00 /

+ (+0.00%)

09/10/20 UBS
United Internet price target raised to EUR 40.5 from EUR 31 at UBS
08/27/20 Barclays
United Internet price target raised to EUR 42 from EUR 40 at Barclays
08/18/20 Commerzbank
United Internet downgraded to Hold from Buy at Commerzbank
05/14/20 DZ Bank
United Internet downgraded to Hold from Buy at DZ Bank
Initiation
TTM Technologies initiated with an Outperform at SMBC Nikko » 05:08
09/21/20
09/21
05:08
09/21/20
05:08
TTMI

TTM Technologies

$11.44 /

-0.01 (-0.09%)

SMBC Nikko initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TTMI TTM Technologies
$11.44 /

-0.01 (-0.09%)

TTMI TTM Technologies
$11.44 /

-0.01 (-0.09%)

07/02/20 Needham
TTM Technologies upgraded to Buy from Hold at Needham
07/02/20 Needham
TTM Technologies upgraded to Buy from Hold at Needham
03/11/20 JPMorgan
JPMorgan downgrades TTM Technologies to Neutral, prefers others in space
03/11/20 JPMorgan
TTM Technologies downgraded to Neutral from Overweight at JPMorgan
TTMI TTM Technologies
$11.44 /

-0.01 (-0.09%)

Upgrade
Portland General Electric upgraded to Buy from Neutral at Mizuho » 05:07
09/21/20
09/21
05:07
09/21/20
05:07
POR

Portland General Electric

$35.01 /

-0.3 (-0.85%)

Mizuho analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
POR Portland General Electric
$35.01 /

-0.3 (-0.85%)

POR Portland General Electric
$35.01 /

-0.3 (-0.85%)

09/16/20 BofA
Portland General Electric upgraded to Buy from Neutral at BofA
09/10/20 Guggenheim
Portland General says no indications of equipment causing fires, says Guggenheim
08/25/20 Seibert Williams
Portland General Electric upgraded to Buy from Hold at Seibert Williams
08/25/20 BofA
Portland General Electric downgraded to Neutral from Buy at BofA
POR Portland General Electric
$35.01 /

-0.3 (-0.85%)

POR Portland General Electric
$35.01 /

-0.3 (-0.85%)

Initiation
Rentokil initiated with a Sell at UBS » 05:06
09/21/20
09/21
05:06
09/21/20
05:06
RTOKY

Rentokil

$0.00 /

+ (+0.00%)

UBS analyst Nicole Manion…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RTOKY Rentokil
$0.00 /

+ (+0.00%)

08/27/20 Morgan Stanley
Rentokil price target raised to 620 GBp from 590 GBp at Morgan Stanley
08/07/20 JPMorgan
Rentokil price target raised to 570 GBp from 560 GBp at JPMorgan
08/03/20 Morgan Stanley
Rentokil price target raised to 590 GBp from 540 GBp at Morgan Stanley
07/24/20 Deutsche Bank
Rentokil price target raised to 550 GBp from 390 GBp at Deutsche Bank
Upgrade
Oracle upgraded to Outperform from Sector Perform at RBC Capital » 05:04
09/21/20
09/21
05:04
09/21/20
05:04
ORCL

Oracle

$59.77 /

-0.43 (-0.71%)

RBC Capital analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORCL Oracle
$59.77 /

-0.43 (-0.71%)

ORCL Oracle
$59.77 /

-0.43 (-0.71%)

09/14/20 Wells Fargo
Oracle deal with TikTok looks like 'win-win,' says Wells Fargo
09/11/20 Societe Generale
Oracle price target raised to $70 from $60 at Societe Generale
09/11/20 RBC Capital
Oracle price target raised to $60 from $51 at RBC Capital
09/11/20 BMO Capital
Oracle price target raised to $63 from $57 at BMO Capital
ORCL Oracle
$59.77 /

-0.43 (-0.71%)

ORCL Oracle
$59.77 /

-0.43 (-0.71%)

ORCL Oracle
$59.77 /

-0.43 (-0.71%)

ORCL Oracle
$59.77 /

-0.43 (-0.71%)

Recommendations
Exelixis price target raised to $33 from $30 at Piper Sandler » 05:03
09/21/20
09/21
05:03
09/21/20
05:03
EXEL

Exelixis

$26.78 /

-0.16 (-0.59%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXEL Exelixis
$26.78 /

-0.16 (-0.59%)

EXEL Exelixis
$26.78 /

-0.16 (-0.59%)

06/30/20 Piper Sandler
Exelixis' 2/3 Phase III Contact studies underway, says Piper Sandler
05/14/20 SunTrust
Exelixis price target raised to $40 from $35 at SunTrust
05/13/20 Piper Sandler
Exelixis mCRPC data for CABOMETYX may accelerate approval, says Piper Sandler
05/06/20 Piper Sandler
Exelixis price target raised to $30 from $23 at Piper Sandler
EXEL Exelixis
$26.78 /

-0.16 (-0.59%)

EXEL Exelixis
$26.78 /

-0.16 (-0.59%)

EXEL Exelixis
$26.78 /

-0.16 (-0.59%)

Recommendations
H.C. Wainwright ups Vir target to $80, sees 'terrific buying opportunity' » 04:59
09/21/20
09/21
04:59
09/21/20
04:59
VIR

Vir Biotechnology

$32.66 /

+0.65 (+2.03%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Patrick Trucchio raised the firm's price target on Vir Biotechnology to $80 from $75 and keeps a Buy rating on the shares. The analyst says the company last week provided a "compelling update" at its Global Investor Conference. Since the emergency authorization of convalescent plasma for COVID-19 on August 23 in the U.S., Vir shares are down 38%, which creates a "terrific buying opportunity ahead of key data readouts," Trucchio tells investors in a research note. The analyst believes the company maintains a leading position in the Covid-19 monoclonal antibody race.

ShowHide Related Items >><<
VIR Vir Biotechnology
$32.66 /

+0.65 (+2.03%)

VIR Vir Biotechnology
$32.66 /

+0.65 (+2.03%)

09/14/20
Fly Intel: Top five analyst upgrades
09/14/20 Goldman Sachs
Vir Biotechnology upgraded to Buy from Neutral at Goldman Sachs
09/11/20 JPMorgan
Vir Biotechnology upgraded to Neutral ahead of catalysts at JPMorgan
09/11/20 JPMorgan
Vir Biotechnology upgraded to Neutral from Underweight at JPMorgan
VIR Vir Biotechnology
$32.66 /

+0.65 (+2.03%)

  • 08
    Jul
  • 11
    Oct
VIR Vir Biotechnology
$32.66 /

+0.65 (+2.03%)

VIR Vir Biotechnology
$32.66 /

+0.65 (+2.03%)

Initiation
Essent Group initiated with a Buy at Goldman Sachs » 04:56
09/21/20
09/21
04:56
09/21/20
04:56
ESNT

Essent Group

$37.20 /

-0.18 (-0.48%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESNT Essent Group
$37.20 /

-0.18 (-0.48%)

ESNT Essent Group
$37.20 /

-0.18 (-0.48%)

06/09/20 Keefe Bruyette
Essent Group downgraded to Market Perform from Outperform at Keefe Bruyette
06/03/20 Credit Suisse
Essent Group price target raised to $38 from $32 at Credit Suisse
06/01/20 Susquehanna
Essent Group price target lowered to $48 from $56 at Susquehanna
06/01/20 B. Riley FBR
B. Riley FBR upgrades Radian on better forbearance data trends
ESNT Essent Group
$37.20 /

-0.18 (-0.48%)

  • 29
    May
ESNT Essent Group
$37.20 /

-0.18 (-0.48%)

Recommendations
Mirati Therapeutics price target raised to $170 from $145 at Piper Sandler » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
MRTX

Mirati Therapeutics

$160.89 /

-1.11 (-0.69%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$160.89 /

-1.11 (-0.69%)

MRTX Mirati Therapeutics
$160.89 /

-1.11 (-0.69%)

09/18/20
Fly Intel: Top five analyst downgrades
09/18/20 Citi
Mirati Therapeutics downgraded to Neutral from Buy at Citi
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/17/20 H.C. Wainwright
Mirati Therapeutics price target raised to $185 from $163 at H.C. Wainwright
MRTX Mirati Therapeutics
$160.89 /

-1.11 (-0.69%)

  • 10
    Jan
MRTX Mirati Therapeutics
$160.89 /

-1.11 (-0.69%)

Conference/Events
Inventiva participates in a webinar with Roth Capital » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
IVA

Inventiva

$11.62 /

-0.48 (-3.97%)

Biotech Analyst Jallah…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IVA Inventiva
$11.62 /

-0.48 (-3.97%)

08/17/20 H.C. Wainwright
Inventiva price target raised to $38 from EUR 12 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst initiations
08/05/20 Roth Capital
Inventiva initiated with a Buy at Roth Capital
08/04/20
Fly Intel: Top five analyst initiations
  • 10
    Jul
Conference/Events
Duke Energy participates in a conference call with Wolfe Research » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
DUK

Duke Energy

$82.94 /

-1.69 (-2.00%)

Utilities & Power…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DUK Duke Energy
$82.94 /

-1.69 (-2.00%)

DUK Duke Energy
$82.94 /

-1.69 (-2.00%)

09/09/20 BofA
Duke Energy upgraded to Buy from Neutral at BofA
09/09/20 BofA
Duke Energy upgraded to Buy from Neutral at BofA
07/07/20 Argus
Dominion price target lowered to $80 from $87 at Argus
07/06/20 Stifel
ACP cancellation negative for mainline pipeline industry overall, says Stifel
DUK Duke Energy
$82.94 /

-1.69 (-2.00%)

  • 19
    Nov
DUK Duke Energy
$82.94 /

-1.69 (-2.00%)

DUK Duke Energy
$82.94 /

-1.69 (-2.00%)

DUK Duke Energy
$82.94 /

-1.69 (-2.00%)

Conference/Events
Royal Caribbean participates in a conference call hosted by Wolfe Reseach » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
RCL

Royal Caribbean

$65.40 /

-3.445 (-5.00%)

Wolfe Research Consumer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCL Royal Caribbean
$65.40 /

-3.445 (-5.00%)

RCL Royal Caribbean
$65.40 /

-3.445 (-5.00%)

08/25/20 Argus
Argus widens Royal Caribbean expected earnings losses
08/12/20 Credit Suisse
Royal Caribbean price target raised to $75 from $67 at Credit Suisse
08/11/20 JPMorgan
Royal Caribbean price target lowered to $67 from $72 at JPMorgan
08/11/20 Stifel
Royal Caribbean price target lowered to $72 from $85 at Stifel
RCL Royal Caribbean
$65.40 /

-3.445 (-5.00%)

RCL Royal Caribbean
$65.40 /

-3.445 (-5.00%)

RCL Royal Caribbean
$65.40 /

-3.445 (-5.00%)

RCL Royal Caribbean
$65.40 /

-3.445 (-5.00%)

Conference/Events
Beam Global management to meet virtually with BTIG » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
BEEM

Beam Global

$12.92 /

+0.08 (+0.62%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BEEM Beam Global
$12.92 /

+0.08 (+0.62%)

Conference/Events
UPS management to meet virtually with KeyBanc » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
UPS

UPS

$159.66 /

-0.13 (-0.08%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UPS UPS
$159.66 /

-0.13 (-0.08%)

UPS UPS
$159.66 /

-0.13 (-0.08%)

09/17/20 Deutsche Bank
FedEx price target raised to $243 from $150 at Deutsche Bank
09/03/20
Fly Intel: Top five analyst downgrades
09/03/20 Berenberg
Berenberg sees 'parcel pair trade,' raises FedEx to Buy and cuts UPS to Sell
09/03/20 Berenberg
UPS downgraded to Sell from Hold at Berenberg
UPS UPS
$159.66 /

-0.13 (-0.08%)

UPS UPS
$159.66 /

-0.13 (-0.08%)

UPS UPS
$159.66 /

-0.13 (-0.08%)

UPS UPS
$159.66 /

-0.13 (-0.08%)

General news
Dallas Federal Reserve Bank President Robert Kaplan Speech to be released at 18:00  04:55
09/21/20
09/21
04:55
09/21/20
04:55
 
General news
6-Month Bill Auction to be released at 11:30  04:55
09/21/20
09/21
04:55
09/21/20
04:55
 
General news
Chicago Fed National Activity Index to be reported at 08:30 » 04:55
09/21/20
09/21
04:55
09/21/20
04:55

August Chicago Fed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
3-Month Bill Auction to be released at 11:30  04:55
09/21/20
09/21
04:55
09/21/20
04:55
 
General news
New York Federal Reserve Bank John Williams Speech to be released at 18:00  04:55
09/21/20
09/21
04:55
09/21/20
04:55
 
Conference/Events
Option Care Health management to virtually meet with Barrington » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
OPCH

Option Care Health

$11.79 /

+0.61 (+5.46%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OPCH Option Care Health
$11.79 /

+0.61 (+5.46%)

OPCH Option Care Health
$11.79 /

+0.61 (+5.46%)

08/05/20 Barrington
Option Care Health price target raised to $19 from $17 at Barrington
07/27/20 Lake Street
Option Care Health weakness a buying opportunity, says Lake Street
06/29/20 Lake Street
Option Care Health should be bought on S-3 filing dip, says Lake Street
06/24/20 BofA
Option Care Health initiated with a Buy at BofA
OPCH Option Care Health
$11.79 /

+0.61 (+5.46%)

  • 22
    Jul
OPCH Option Care Health
$11.79 /

+0.61 (+5.46%)

Conference/Events
Cimpress management to meet virtually with Truist » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
CMPR

Cimpress

$77.07 /

-3.49 (-4.33%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMPR Cimpress
$77.07 /

-3.49 (-4.33%)

CMPR Cimpress
$77.07 /

-3.49 (-4.33%)

08/17/20 Barrington
Cimpress upgraded to Outperform from Market Perform at Barrington
07/30/20 SunTrust
Cimpress upgraded to Buy from Hold at SunTrust
07/30/20 SunTrust
Cimpress upgraded to Buy from Hold at SunTrust
03/27/20 SunTrust
Cimpress price target lowered to $68 from $130 at SunTrust
CMPR Cimpress
$77.07 /

-3.49 (-4.33%)

CMPR Cimpress
$77.07 /

-3.49 (-4.33%)

Conference/Events
Jefferies biotech analyst to hold an analyst/industry conference call » 04:55
09/21/20
09/21
04:55
09/21/20
04:55
IMMU

Immunomedics

$85.50 /

+0.19 (+0.22%)

, GILD

Gilead

$65.05 /

+0.03 (+0.05%)

Biotech Analyst Howerton,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

09/20/20 Citi
Immunomedics presents at ESMO, readouts exceeded expectations, says Citi
09/20/20 Piper Sandler
Immunomedics ASCENT data 'an absolute slam dunk,' says Piper Sandler
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/17/20 Piper Sandler
Novocure price target raised to $125 from $89 at Piper Sandler
GILD Gilead
$65.05 /

+0.03 (+0.05%)

09/20/20 Citi
Immunomedics presents at ESMO, readouts exceeded expectations, says Citi
09/18/20 RBC Capital
Gilead price target raised to $86 from $82 at RBC Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 Maxim
Gilead upgraded to Buy at Maxim following Immunomedics deal
IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

  • 29
    Apr
  • 05
    Dec
IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

IMMU Immunomedics
$85.50 /

+0.19 (+0.22%)

GILD Gilead
$65.05 /

+0.03 (+0.05%)

Conference/Events
Benchmark tech analyst to hold an analyst/industry conference call » 04:55
09/21/20
09/21
04:55
09/21/20
04:55

Technology Analyst Jiang,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.